Medicare Enrolled

Dr. Azita Taghavy, M.D.

Optician · Greenbrae, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
250 BON AIR RD,, Greenbrae, CA 94904
5102303320
In practice since 2008 (17 years)
NPI: 1295980431 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Taghavy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Taghavy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Taghavy

Dr. Azita Taghavy is an optician specialist in Greenbrae, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Taghavy performed 6,656 Medicare services across 1,705 unique beneficiaries.

Between the years covered by Open Payments, Dr. Taghavy received a total of $4,463 from 22 pharmaceutical and/or device companies across 187 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Taghavy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 13% volume in CA $4,463 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,656
Medicare services
Top 13% in CA for optician
1,705
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~392 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 3,962 $18 $30
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
865 $80 $150
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
529 $44 $91
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
299 $157 $241
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
292 $12 $75
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
152 $13 $44
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
123 $55 $139
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
102 $85 $216
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
83 $37 $45
Flu vaccine, quadrivalent
A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection.
82 $76 $94
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
74 $1 $5
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
43 $114 $219
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
32 $22 $46
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
18 $121 $305
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,463
Total received (2019-2024)
Avg $893/year across 5 years
Top 25% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
187
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,463 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,634
2023
$1,661
2022
$1,039
2021
$86
2019
$43

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$203
PFIZER INC.
$203
ABBVIE INC.
$195
Amgen Inc.
$175
Novo Nordisk Inc
$168
Boehringer Ingelheim Pharmaceuticals, Inc.
$163
AstraZeneca Pharmaceuticals LP
$148
Biogen, Inc.
$61
Janssen Pharmaceuticals, Inc
$58
Astellas Pharma US Inc
$51
E.R. Squibb & Sons, L.L.C.
$45
Amneal Pharmaceuticals LLC
$45
Sumitomo Pharma America, Inc.
$38
Merck Sharp & Dohme LLC
$30
Radius Health, Inc.
$28
SANOFI PASTEUR INC.
$24
Top 3 companies account for 36.8% of 2024 payments
All-time payments by company (2019-2024) ›
Amgen Inc.
$664
Novo Nordisk Inc
$429
Astellas Pharma US Inc
$409
Boehringer Ingelheim Pharmaceuticals, Inc.
$388
AstraZeneca Pharmaceuticals LP
$381
Lilly USA, LLC
$324
PFIZER INC.
$293
Janssen Pharmaceuticals, Inc
$282
ABBVIE INC.
$251
AbbVie Inc.
$197
GlaxoSmithKline, LLC.
$174
Merck Sharp & Dohme LLC
$140
ViiV Healthcare Company
$85
Sumitomo Pharma America, Inc.
$83
E.R. Squibb & Sons, L.L.C.
$72
Biogen, Inc.
$61
Vanda Pharmaceuticals Inc.
$61
Biohaven Pharmaceutical Holding Company Ltd.
$52
Amneal Pharmaceuticals LLC
$45
Radius Health, Inc.
$28
SANOFI PASTEUR INC.
$24
Xeris Pharmaceuticals, Inc.
$20
Top 3 companies account for 33.7% of all-time payments
Associated products mentioned in payments ›
APRETUDE · AREXVY · BELSOMRA · BREZTRI · CAMZYOS · CREON · CREXONT · ELIQUIS · EMGALITY · EVENITY · FANAPT · FARXIGA · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · GARDASIL · GARDASIL 9 · GEMTESA · GVOKE HYPOPEN · HETLIOZ · JARDIANCE · MOUNJARO · Myrbetriq · NURTEC ODT · Otezla · Ozempic · PNEUMOVAX 23 · PREMARIN · QULIPTA · RYTARY · Repatha · Rybelsus · SHINGRIX · SKYCLARYS · SPRAVATO · STIOLTO RESPIMAT · SYNTHROID · TRELEGY ELLIPTA · TRULICITY · Tymlos · UBRELVY · VYNDAQEL · Veozah · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an optician specialist in Greenbrae?
Compare opticians in the Greenbrae area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
1,091
Per 100K population
421.6
County median income
$142,785
Nearest hospital
MARINHEALTH MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Taghavy is a clinical cardiology specialist, with above-average Medicare volume (top 13% in CA), with low-engagement industry engagement, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Taghavy experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Taghavy performed 3,962 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Taghavy receive payments from pharmaceutical companies?
Yes. Dr. Taghavy received a total of $4,463 from 22 companies across 187 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Taghavy's costs compare to other opticians in Greenbrae?
Dr. Taghavy's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Taghavy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →